StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.54−0.50 (-5.53%)

Close on Nov 16, 2026Market cap $297.90MP/E –Yield –

How the market prices Benitec Biopharma

Each ratio against its own distribution since 2019, from month-end prices and the figures reported at the time

Benitec Biopharma trades at 1.7× its earnings, against a median of 27.4× since 2019 — cheaper than 97% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2019, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to book since 2019

Median 27.4×, today 1.7×

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-33.2%vs -53.5%
Return on assets-32.3%vs -40.7%
Return on capital employed-28.9%vs -38.7%

How hard the assets work

Profit per employee-$1.90Mvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $179.97M. That is 152.6% of the $117.93M it would cost to buy the business outright.

Cash and short-term investments$179.97M
EBITDA, trailing twelve months-$51.13M
Free cash flow, trailing twelve months-$16.62M

Leverage and liquidity

Current ratio34.00vs 3.30
Quick ratio33.68vs 2.39

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

30.00
DistressSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

3 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-15.3%vs -22.5%
Free cash flow yield-5.58%vs -9.27%
Buyback yield-35.1%vs -0.65%
Shareholder yield-35.1%vs 0.00%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 16, 2026

$7.8852-week low52-week high$14.39
$8.5420-day50-day200-day

The close sits 10% of the way up the 52-week range, 40.7% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

43
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

BNTCS&P 500
PeriodBNTCS&P 500DifferenceBNTC per yearS&P 500 per year
1 month+5.3%-3.1%+8.4 pts
3 months-32.0%-4.5%−27.6 pts
Year to date-36.6%+9.4%−46.0 pts
1 year-35.1%+11.3%−46.4 pts
3 years+137.9%+70.4%+67.5 pts+33.5%+19.4%
5 years-85.4%+68.6%−153.9 pts-31.9%+11.0%
10 years-97.7%+297.7%−395.4 pts-31.5%+14.8%

How much it moves

Volatility, 1 year58.0%vs 80.4%
Volume against its 90-day average0.81vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M BNTC shares were sold short on Oct 30, 2026, up 0.1% from the previous report, or 35.99% of the shares available to trade. At recent volumes it would take 11.3 days to buy them back. Over the last 20 sessions, 53.2% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float36.0%vs 8.91%
Short interest as a share of all shares5.72%vs 6.30%
Days of volume to buy it back11.30vs 5.16

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,994,400+0.1%176,53011.3
Oct 15, 20261,992,032-2.3%197,76110.1
Sep 30, 20262,039,457-6.7%200,14710.2
Sep 15, 20262,186,142-1.3%109,46320.0
Aug 31, 20262,214,538+5.1%154,96214.3
Aug 14, 20262,107,348-1.8%211,9869.9
Jul 31, 20262,146,708-5.4%80,28326.7
Jul 15, 20262,269,662+1.8%96,65723.5
Jun 30, 20262,228,682-7.3%214,32210.4
Jun 15, 20262,405,071+3.1%83,37028.9
May 29, 20262,332,180+3.6%75,77930.8
May 15, 20262,251,632-2.9%97,93523.0

Every measure, in full

64 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 11, 2027 (estimated, before the open)
Last ex-dividend date
Jun 1, 2018
Fundamentals through
Jun 30, 2026
Share price as of
Nov 16, 2026

Valuation ratiosIndustry

Market Cap
$297.90M
$261.21M
Enterprise Value
$117.93M
$135.05M
PB Ratio
1.68
2.00
P/TBV Ratio
1.68
2.22

Share statisticsIndustry

Shares Change (YoY)
28.6%
10.9%
Shares Change (QoQ)
0.18%
0.57%
Float
6M
49M
Shares Held by Insiders
84.1%
11.2%
Shares Held by Institutions
99.4%
56.2%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
0.12%
-0.81%
Short % of Float
36.0%
8.91%
Short % of Shares Outstanding
5.72%
6.30%
Days to Cover
11.30
5.16

Stock price statisticsIndustry

52-Week High
$14.39
–
52-Week Low
$7.88
–
20-Day Moving Average
$8.91
–
50-Day Moving Average
$9.59
–
200-Day Moving Average
$11.37
–
Average True Range (14)
$0.69
–
Price Change (1 Week)
-13.5%
-7.55%
Price Change (1 Month)
5.30%
-4.88%
Price Change (3 Months)
-33.7%
-24.2%
Price Change (6 Months)
-21.6%
-21.7%
Price Change (YTD)
-36.6%
-26.2%
Price Change (1 Year)
-35.1%
-22.5%
Price Change (3 Years)
149.0%
-31.7%
Price Change (5 Years)
-85.3%
-78.2%
Price Change (10 Years)
-97.8%
-67.5%
Average Volume (10 Days)
200,457
–
Average Volume (20 Days)
193,210
–
Average Volume (90 Days)
164,278
–
Relative Volume
0.81
0.86
Relative Strength Index (14)
43.3
40.8
Volatility (1 Year)
58.0%
80.4%

Returns on capitalIndustry

Return on Equity (ROE)
-33.2%
-53.5%
Return on Assets (ROA)
-32.3%
-40.7%
Return on Capital Employed (ROCE)
-28.9%
-38.7%

Financial positionIndustry

Current Ratio
34.00
3.30
Quick Ratio
33.68
2.39

EfficiencyIndustry

Profits Per Employee
-$1.90M
-$704.12K
Employee Count
24
75

Income statement (TTM)Industry

Operating Income
-$51.19M
-$21.49M
Net Income
-$45.55M
-$22.47M
EBITDA
-$51.13M
-$17.14M
EPS (Diluted)
-$0.98
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$179.97M
$15.35M
Net Cash Per Share
$5.16
$0.71
Equity (Book Value)
$177.01M
$49.84M
Book Value Per Share
$5.07
$1.45
Tangible Book Value
$177.01M
$23.91M
Working Capital
$176.34M
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
-$16.52M
-$12.17M
Capital Expenditures
-$105.00K
-$1.03M
Free Cash Flow
-$16.62M
-$20.28M
FCF Per Share
-$0.48
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-15.3%
-22.5%
FCF Yield
-5.58%
-9.27%
Buyback Yield
-35.1%
-0.65%
Shareholder Yield
-35.1%
0.00%

Scores and fair valueIndustry

Altman Z-Score
30.00
0.22
Piotroski F-Score
3
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?